This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Cabozantinib-S-Malate

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Cabozantinib-S-Malate Means in Everyday Medical Language

Cabozantinib-S-Malate is a cancer medicine that targets specific proteins inside cancer cells and their surroundings. These proteins send signals that encourage cancer cells to grow and divide, and they also help tumors build new blood vessels to get oxygen and nutrients. By blocking these signals, cabozantinib-s-malate can slow down or stop cancer growth and spread. It is a type of targeted therapy called a kinase inhibitor and is taken as a small-molecule drug, meaning it can enter cancer cells easily to reach its targets.

Why Cabozantinib-S-Malate Can Matter in Cancer Care

This drug offers a more focused approach than traditional chemotherapy by targeting the biology of cancer cells and the blood vessels tumors need. It is used mainly for certain thyroid cancers (including medullary and differentiated types), liver cancer (hepatocellular carcinoma), kidney cancer (renal cell carcinoma), and some neuroendocrine tumors. Cabozantinib-s-malate is often prescribed when cancers have spread or have not responded well to other treatments. By blocking blood vessel growth, it limits the tumor’s ability to get nutrients and oxygen, which is important for slowing cancer progression.

What Patients Might See or Hear About Cabozantinib-S-Malate

Patients may hear about cabozantinib-s-malate under brand names like Cabometyx or Cometriq during visits with their cancer care team, in treatment plans, or on drug information sheets. It may be mentioned as a treatment option for advanced or spreading thyroid, liver, kidney, or neuroendocrine cancers. Sometimes it is combined with other therapies, such as immunotherapy, especially for kidney cancer. Patients might also find information about this drug when exploring clinical trials for new cancer treatments.

What Cabozantinib-S-Malate Does Not Automatically Mean

Hearing about cabozantinib-s-malate does not mean the cancer will definitely shrink or disappear. It is not a cure but a treatment aimed at controlling cancer growth or spread. It also does not mean the drug is suitable for every patient or every type of cancer. Doctors decide to use it based on the cancer type, previous treatments, and overall health. Its use is one part of a larger treatment plan tailored to each patient’s situation.

Questions to Ask Your Care Team About Cabozantinib-S-Malate

It can help to ask how this drug fits into your overall treatment plan, what side effects to expect, and how doctors will monitor if it is working. You might also ask about possible interactions with other medicines and what lifestyle changes could support your health during treatment. Understanding these points can help you feel more confident and involved in your care.

Safety and Context

This information is educational and not a substitute for medical advice. Cabozantinib-s-malate can cause side effects that need careful management, including risks related to blood vessel health and bleeding. Only your healthcare provider can determine if this drug is right for you based on your health and cancer type. Always discuss your treatment options and concerns openly with your care team.

Next Steps for Patients and Caregivers

If you or a loved one is starting treatment with cabozantinib-s-malate, the next step is to talk openly with your doctor or nurse about what to expect, how to manage side effects, and how this drug fits into your overall care plan. Understanding your treatment helps you feel more confident and involved in your care journey.

Sources

Public source information used for this glossary entry includes: